PMID:20332210: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
New PMID: Page!
 
Fill PMID: Page!
Line 1: Line 1:
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181284.O4f88cb2500c70-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="O4f88cb2500c70"  class=" tableEdit PMID_info_table" 


|-
!align=left  |Citation
||
'''Zhang, K, Li, H, Cho, KM and Liao, JC'''  (2010) Expanding metabolism for total biosynthesis of the nonnatural amino acid L-homoalanine.''Proc. Natl. Acad. Sci. U.S.A.'' '''107''':6234-9
|-
!align=left  |Abstract
||
The dramatic increase in healthcare cost has become a significant burden to the world. Many patients are denied the accessibility of medication because of the high price of drugs. Total biosynthesis of chiral drug intermediates is an environmentally friendly approach that helps provide more affordable pharmaceuticals. Here we have expanded the natural metabolic capability to biosynthesize a nonnatural amino acid L-homoalanine, which is a chiral precursor of levetiracetam, brivaracetam, and ethambutol. We developed a selection strategy and altered the substrate specificity of ammonium-assimilating enzyme glutamate dehydrogenase. The specificity constant k(cat)/K(m) of the best mutant towards 2-ketobutyrate is 50-fold higher than that towards the natural substrate 2-ketoglutarate. Compared to transaminase IlvE and NADH-dependent valine dehydrogenases, the evolved glutamate dehydrogenase increased the conversion yield of 2-ketobutyrate to L-homoalanine by over 300% in aerobic condition. As a result of overexpressing the mutant glutamate dehydrogenase and Bacillus subtilis threonine dehydratase in a modified threonine-hyperproducing Escherichia coli strain (ATCC98082, DeltarhtA), 5.4 g/L L-homoalanine was produced from 30 g/L glucose (0.18 g/g glucose yield, 26% of the theoretical maximum). This work opens the possibility of total biosynthesis of other nonnatural chiral compounds that could be useful pharmaceutical intermediates.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20332210 PubMed]
Online version:[http://dx.doi.org/10.1073/pnas.0912903107 10.1073/pnas.0912903107]
|-
!align=left  |Keywords
||
Amination; Aminobutyric Acids; Bacillus subtilis; Butyric Acids; Escherichia coli; Glutamate Dehydrogenase; Models, Molecular; Molecular Structure; Mutation; Protein Structure, Tertiary; Streptomyces; Substrate Specificity
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.181284.O4f88cb2500c70&page=181284&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181284.O4f88cb2500c70-->
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==
{{LitMaterials}}
==Annotations {{HelpIcon|Help:Literature}}==
<protect><!--box uid=d41d8cd98f00b204e9800998ecf8427e.181284.V4f88cb2505284-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="V4f88cb2505284"  class=" tableEdit GO_table_reference dataTable" 
|- {{table heading style}}
!|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.181284.V4f88cb2505284&page=181284&pagename={{FULLPAGENAMEE}}&type=0&template=GO_table_reference edit table]</span> || || || || || || || ||
|}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.181284.V4f88cb2505284--></protect>
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==
{{LitLinks}}
==See also==
==References==
{{RefHelp}}
<references/>

Revision as of 00:56, 14 April 2012

Citation

Zhang, K, Li, H, Cho, KM and Liao, JC (2010) Expanding metabolism for total biosynthesis of the nonnatural amino acid L-homoalanine.Proc. Natl. Acad. Sci. U.S.A. 107:6234-9

Abstract

The dramatic increase in healthcare cost has become a significant burden to the world. Many patients are denied the accessibility of medication because of the high price of drugs. Total biosynthesis of chiral drug intermediates is an environmentally friendly approach that helps provide more affordable pharmaceuticals. Here we have expanded the natural metabolic capability to biosynthesize a nonnatural amino acid L-homoalanine, which is a chiral precursor of levetiracetam, brivaracetam, and ethambutol. We developed a selection strategy and altered the substrate specificity of ammonium-assimilating enzyme glutamate dehydrogenase. The specificity constant k(cat)/K(m) of the best mutant towards 2-ketobutyrate is 50-fold higher than that towards the natural substrate 2-ketoglutarate. Compared to transaminase IlvE and NADH-dependent valine dehydrogenases, the evolved glutamate dehydrogenase increased the conversion yield of 2-ketobutyrate to L-homoalanine by over 300% in aerobic condition. As a result of overexpressing the mutant glutamate dehydrogenase and Bacillus subtilis threonine dehydratase in a modified threonine-hyperproducing Escherichia coli strain (ATCC98082, DeltarhtA), 5.4 g/L L-homoalanine was produced from 30 g/L glucose (0.18 g/g glucose yield, 26% of the theoretical maximum). This work opens the possibility of total biosynthesis of other nonnatural chiral compounds that could be useful pharmaceutical intermediates.

Links

PubMed Online version:10.1073/pnas.0912903107

Keywords

Amination; Aminobutyric Acids; Bacillus subtilis; Butyric Acids; Escherichia coli; Glutamate Dehydrogenase; Models, Molecular; Molecular Structure; Mutation; Protein Structure, Tertiary; Streptomyces; Substrate Specificity

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status


EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

See also

References

See Help:References for how to manage references in EcoliWiki.